About
234.90EUR+5.00 +2.17%
Closed • Updated at 14:41 GMT+00:00Market Cap$50.92B
P/E Ratio29.28
Volume63.9K
Beta1.64
RSI43.67
Gross Margin71.14%
Ucb S.a. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 27 2026
UCB - Convening Notice to the General Meeting of the Shareholders 2026
Sep 10 2025
Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
Aug 29 2025
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
Aug 5 2025
UCB's HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment
Jul 8 2025
UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
Recent Videos

🙏🤗 Ți s-a întâmplat să-ți simți sufletul înfometat? ... 😇😊 #isus #biblia #suflet
May 18, 2026

UCB & Cancer Research UK Join Forces for Next-Gen Cancer Therapies 🚀
May 07, 2026

UCB SA Deep Dive | The Margin Shift Driving 79% EBITDA Growth
May 04, 2026

https://studio.youtube.com/channel/UCb-mHQ2d0WXYtikg1KH373w/collaboration/UCupnWzMGHRZzqbIEppGknYA
Apr 29, 2026
Google Übersetzer